QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
NASDAQ:ULBI

Ultralife (ULBI) Stock Price, News & Analysis

$8.81
+0.03 (+0.34%)
(As of 05:17 PM ET)
Today's Range
$8.65
$8.89
50-Day Range
$7.19
$9.96
52-Week Range
$3.92
$11.85
Volume
24,478 shs
Average Volume
59,238 shs
Market Capitalization
$144.92 million
P/E Ratio
20.02
Dividend Yield
N/A
Price Target
$13.00

Ultralife MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
47.6% Upside
$13.00 Price Target
Short Interest
Healthy
1.10% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.48mentions of Ultralife in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$8,600 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.50 out of 5 stars

Computer And Technology Sector

232nd out of 587 stocks

Miscellaneous Electrical Machinery, Equipment, & Supplies Industry

5th out of 24 stocks

ULBI stock logo

About Ultralife Stock (NASDAQ:ULBI)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle adapters, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. This segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. The company sells its products under the Ultralife, Ultralife HiRate, Ultralife Thin Cell, Ultralife Batteries, Lithium Power, McDowell Research, AMTITM, ABLETM, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE SEASAFE, Excell Battery Group, and Criterion Gauge brands through original equipment manufacturers, and industrial and defense supply distributors. In addition, it sells its 9-volt battery to the broader consumer market through national and regional retail chains and online retailers. It serves government, defense, and commercial sectors. The company was incorporated in 1990 and is headquartered in Newark, New York.

ULBI Stock Price History

ULBI Stock News Headlines

Ultralife (ULBI) Scheduled to Post Earnings on Thursday
AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
ULBI Apr 2024 5.000 put
AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
Ultralife Corp
What Wall Street expects from Ultralife Batteries's earnings
Ultralife Corporation Reports Fourth Quarter Results
Ultralife Corporation Reports Fourth Quarter Results
Ultralife: Buy The Dip
Ultralife Corp ULBI
Ultralife: Q3 Earnings Snapshot
See More Headlines
Receive ULBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ultralife and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/15/2024
Today
4/18/2024
Next Earnings (Confirmed)
4/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Miscellaneous electrical machinery, equipment, & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:ULBI
Employees
536
Year Founded
1990

Price Target and Rating

Average Stock Price Target
$13.00
High Stock Price Target
$13.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+48.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$7.20 million
Pretax Margin
5.75%

Debt

Sales & Book Value

Annual Sales
$158.64 million
Cash Flow
$0.75 per share
Book Value
$7.68 per share

Miscellaneous

Free Float
9,426,000
Market Cap
$143.94 million
Optionable
Optionable
Beta
1.26

Social Links

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

ULBI Stock Analysis - Frequently Asked Questions

Should I buy or sell Ultralife stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ultralife in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ULBI shares.
View ULBI analyst ratings
or view top-rated stocks.

What is Ultralife's stock price target for 2024?

1 Wall Street research analysts have issued 1 year target prices for Ultralife's stock. Their ULBI share price targets range from $13.00 to $13.00. On average, they anticipate the company's share price to reach $13.00 in the next twelve months. This suggests a possible upside of 47.6% from the stock's current price.
View analysts price targets for ULBI
or view top-rated stocks among Wall Street analysts.

How have ULBI shares performed in 2024?

Ultralife's stock was trading at $6.82 at the beginning of the year. Since then, ULBI shares have increased by 29.2% and is now trading at $8.81.
View the best growth stocks for 2024 here
.

Are investors shorting Ultralife?

Ultralife saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 105,600 shares, a decline of 18.1% from the March 15th total of 128,900 shares. Based on an average trading volume of 62,100 shares, the short-interest ratio is currently 1.7 days. Currently, 1.1% of the shares of the company are sold short.
View Ultralife's Short Interest
.

When is Ultralife's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our ULBI earnings forecast
.

How can I listen to Ultralife's earnings call?

Ultralife will be holding an earnings conference call on Thursday, April 25th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Ultralife's earnings last quarter?

Ultralife Co. (NASDAQ:ULBI) announced its quarterly earnings results on Thursday, February, 15th. The technology company reported $0.18 earnings per share (EPS) for the quarter. The technology company earned $44.55 million during the quarter. Ultralife had a net margin of 4.54% and a trailing twelve-month return on equity of 7.36%.

What other stocks do shareholders of Ultralife own?
How do I buy shares of Ultralife?

Shares of ULBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Ultralife have any subsidiaries?
The following companies are subsidiares of Ultralife: ABLE New Energy Co. Limited, Accutronics Ltd., CLB Inc., Southwest Electronic Energy Corporation, Ultralife Batteries (UK) LTD, Ultralife Batteries India Private Limited, Ultralife Energy Services Corporation, and Ultralife UK LTD.
Read More
This page (NASDAQ:ULBI) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners